Hyloris Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2017
Period Ending	Nov '24 Nov 21, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2017
Market Capitalization	162	357	311	447	245	-	Upgrade
Market Cap Growth	6.85%	14.84%	-30.44%	82.11%	-	-	Upgrade
Enterprise Value	136	319	260	402	187	-	Upgrade
Last Close Price	5.80	12.75	11.60	17.30	9.50	-	Upgrade
PS Ratio	23.79	84.72	130.24	144.35	1402.34	-	Upgrade
PB Ratio	4.86	9.14	5.77	9.30	4.16	-	Upgrade
P/TBV Ratio	10.62	9.57	5.97	9.67	4.26	-	Upgrade
EV/Sales Ratio	19.64	75.71	108.83	129.77	1068.71	-	Upgrade
Debt / Equity Ratio	0.05	0.04	0.02	0.18	0.14	-1.30	Upgrade
Asset Turnover	0.14	0.08	0.04	0.05	0.00	0.01	Upgrade
Quick Ratio	3.66	5.14	8.33	3.53	30.33	0.03	Upgrade
Current Ratio	3.71	5.22	8.63	3.60	31.24	0.23	Upgrade
Return on Equity (ROE)	-31.76%	-33.08%	-23.35%	-21.62%	-29.24%	-	Upgrade
Return on Assets (ROA)	-16.75%	-18.27%	-11.58%	-9.73%	-8.44%	-18.58%	Upgrade
Return on Capital (ROIC)	-19.79%	-20.72%	-12.89%	-10.38%	-9.00%	-32.74%	Upgrade
Earnings Yield	-8.03%	-4.31%	-3.83%	-2.59%	-2.91%	-	Upgrade
FCF Yield	-7.60%	-3.67%	-4.22%	-2.54%	-1.86%	-	Upgrade
Buyback Yield / Dilution	-1.44%	-2.95%	-5.29%	-18.40%	-51.63%	-6.43%	Upgrade
Total Shareholder Return	-1.44%	-2.95%	-5.29%	-18.40%	-51.63%	-6.43%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.